Project Grant R21AI196191
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a $3,045,291 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, through July 31, 2029. This collaborative research initiative, led by the Carette, Chiu, and Nagamine laboratories, focuses on elucidating the molecular mechanisms by which the MFSD6 (Major Facilitator Superfamily Domain-containing...
- Federal Grant Award Summary The Leland Stanford Junior University received a $151,040 Project Grant award, effective February 25, 2026, through September 17, 2028, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports investigator-initiated biomedical research focused on understanding and controlling neutrophil migration through manipulation of nuclear deformability—a critical objective...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant totaling $160,448 (Award Date: February 15, 2026; Completion Date: August 31, 2028) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funded research aims to develop activity-based probes (ABPs)—covalent theranostic probes targeting bacterial D,D-carboxypeptidases—for the targeted imaging and photodynamic...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $150,104 to The Leland Stanford Junior University on March 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). This award supports research to develop a predictive spillover model for Japanese Encephalitis Virus (JEV) risk in the United States through the completion date of October 31, 2028. The project addresses a critical knowledge gap...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $153,512 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on December 13, 2025, with completion scheduled for June 30, 2026. This award supports research aimed at characterizing the renal immune microenvironment in antibody-mediated rejection (ABMR) to predict treatment response using imaging mass cytometry. The...
- Federal Grant Award Summary Tufts University School of Medicine received a $243,600 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on February 23, 2026, with completion by January 31, 2028. The grant funds research investigating the role of CLCC1, an endoplasmic reticulum protein, in herpesvirus nuclear egress—a critical early step in viral replication where herpes simplex...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $771,210 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct biomedical research on Salmonella persistence mechanisms. The award, effective February 19, 2026, with a completion date of January 31, 2031, supports research investigating how Salmonella enterica serovar Typhimurium (STM) maintains persistent...
- Federal Grant Award Summary Tufts University School of Medicine received a $7.04M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct a four-year investigation into the mechanisms of nuclear egress in herpesviruses. The award, effective August 1, 2025, through July 31, 2029, funds research on how herpesviruses export their capsids from the cell nucleus to the cytoplasm through a...
- Federal Grant Award Summary Stanford University received a $423,500 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on July 25, 2025, with completion targeted for June 30, 2027. This research project investigates antimicrobial peptides and antibiotic diffusion in sputum to address treatment challenges in cystic fibrosis (CF) patients. The research focuses on understanding how...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant totaling $789,442 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 17, 2025, with a completion date of June 30, 2030. This research initiative employs multi-omics approaches—including single-cell proteomic and transcriptomic analyses—to investigate how the immune system adapts to repeated Plasmodium...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Leland Stanford Junior University a Project Grant of $246,881 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for cryo-electron microscopy (cryo-EM) research on herpesvirus glycoprotein complexes. The award, announced on February 13, 2026, with completion targeted for January 31, 2028, funds structural research on varicella-zoster virus (VZV) glycoproteins essential to viral entry and immune evasion. The project will deliver near-atomic resolution structures of two critical glycoprotein complexes: GB/GH-GL (the core fusion machinery required for cell entry) and GE/GI (involved in viral replication and immune recognition), utilizing advanced cryo-EM techniques combined with cyclapol-based membrane extraction to capture proteins in their native membrane environment. This research addresses a significant gap in understanding herpesvirus membrane fusion mechanisms and antibody recognition targets, overcoming limitations of computational protein prediction models in characterizing dynamic protein-protein interactions within membrane-associated complexes. The project comprises two primary objectives: determining the GB/GH-GL fusion complex structure and its functional relationships, and characterizing the GE/GI complex independently and in interaction with antibodies. Work will be conducted at Stanford's Palo Alto, California facility, where preliminary data has already demonstrated successful purification of both glycoprotein complexes from VZV-infected cells, establishing feasibility for the structural determination goals.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $246.9k | 2/13/26 |